EP300 and gastric adenocarcinoma: Furthermore, we found that EP300-mutated cancers showed significantly higher programmed death-ligand 1 (PD-L1) expression levels than EP300-wild-type cancers in four cancer types, including BLCA, HNSC, UCEC, and STAD (Figure 2D).